Analysis of the Range of Medicines used in the Treatment of Skin Diseases

The purpose of this article is to analyze the range of medicines that are used in the treatment of skin diseases. This topic is currently relevant, since the analysis of retail sales allows you to assess the financial condition of a pharmacy organization, identify unclaimed drugs, develop measures to stimulate sales, as well as study customer demand and develop a strategy for product movement. Accordingly, conducting a study of the main indicators of the assortment of this group of drugs will make it possible to expand their representation on the shelves of pharmacies, as well as to study the demand for them from potential consumers. During the analysis, the following data were obtained. The range under study was represented in Original Research Article Akhtaev et al.; JPRI, 33(12): 29-36, 2021; Article no.JPRI.66280 30 the pharmacy by 22 items. The analysis of dosage forms of medicines intended for the treatment of skin diseases showed that liquid dosage forms accounted for 22.73%; solid dosage forms 4.55%; soft dosage forms – 59.08%; gaseous dosage forms -13.64%. When analyzing the drugs, it was revealed that the largest number in the assortment is synthetic drugs 68.18%; the share of phytopreparations was 31.82%. Analysis of the producing countries showed that most of the drugs presented to the pharmacy by domestic producers (54,53%), in the second place drugs manufactured in India -18,17%; third place was shared by countries: Poland, Croatia, Belgium, Germany, Czech Republic, USA -4,55%. The analysis of price categories of pharmaceuticals for the treatment of skin diseases revealed that in the price category from 100 to 200 RUB presents 22,73% of drugs; in the category from 200 to 300 rubles-49,89%; from 300 to 400 rubles from 33.73%; from 400 to 700 rubles on 4,55%.


INTRODUCTION
Drugs used for the treatment of skin diseases are in high steady demand in pharmacy organizations [1]. The reason for this is that the spread of these diseases is very dynamic due to the infectious nature of some of them, as well as due to the insufficiently unfavorable environmental background. As a result of the development of such diseases in a person since childhood, he is forced to use some drugs of this group constantly. For this reason, the availability of such medicines in pharmacies is a mandatory factor that allows improving the quality of life for those suffering from skin diseases [2,3,4]. In addition, the range of such medicines will allow patients to purchase a drug that is affordable for them at a price and quality. The purpose of the work is to analyze the range of medicines that are used in the treatment of skin diseases.

MATERIALS AND METHODS
The analysis was carried out on the materials of the pharmacy network "World of Medicines", which operates in Belgorod. In the process of writing the work, the calculation method, the graphical method, and the comparative method were used.

RESULTS
The main stage of studying the market of medicines is assortment analysis [5]. Table 1 shows the range of medicines used for the treatment of skin diseases available in the pharmacy.
As can be seen from Table 1, in the pharmacies of this network, this group of drugs is represented by 22 names.
Also, the structure of the analysis necessarily includes the study of medicinal forms of drugs [6]. We will analyze the dosage forms, medicines intended for the treatment of skin diseases ( Table 2).
The analysis of dosage forms of medicines intended for the treatment of skin diseases showed that liquid dosage forms accounted for 22.73%; solid dosage forms -4.55%; soft dosage forms -59.08%; gaseous dosage forms -13.64%. The structure of medicines by type of dosage forms is shown in Fig. 1. Fig. 1, it can be said that the largest number of soft dosage forms are left in the structure of medicines intended for the treatment of skin diseases.

DISCUSSION
Medicines intended for the treatment of skin diseases can be of both synthetic and plant origin [7]. We will analyze the studied group of drugs by composition (INN) ( Table 3). Table 3, it can be indicated that the range includes both synthetic and plant-based preparations.

Based on
In the literature, a structural analysis of drugs is also carried out [8] In Table 4, a structural analysis of the studied group of drugs by composition is carried out.   Based on Table 4, it can be said that the largest number of synthetic drugs in the assortment is 68.18%; the share of herbal products was 31.82%. The structure of the composition of drugs intended for the treatment of skin diseases is shown in Fig. 2.
In addition, the study of medicines should include an analysis of medicines in the context of the  Based on Table 4, it can be said that the largest number of synthetic drugs in the assortment is share of herbal products was 31.82%. The structure of the composition of drugs intended for the treatment of skin diseases In addition, the study of medicines should include an analysis of medicines in the context of the producing countries [9]. In the range of medicines intended for the treatment of skin diseases, there are drugs available, both domestic and foreign manufacturers ( Table 5).
We will analyze the countries of manufacturers of medicines used for the treatment of skin diseases in Table 6. tries [9]. In the range of medicines intended for the treatment of skin diseases, there are drugs available, both domestic and foreign manufacturers We will analyze the countries of manufacturers of treatment of skin

Producing country
Synthetic drugs,

Analysis of the countries of manufacturers of medicines used in the treatment of skin diseases
The amount of products

Analysis of the countries of manufacturers of medicines used in the treatment of skin
The ranking of countries treatment of skin diseases  From 300 to 400 rubles 4

Prices for medicines for the treatment of skin diseases in the network of pharmacies
From 400 to 500 rubles 5 From 500 to 600 rubles 6 From 600 to 700 rubles Total

Fig. 4. Structure of price categories of medicines intended for the treatment of skin diseases
The structure of the countries producing medicines intended for the treatment of skin diseases is shown in Fig. 3.
Based on Fig. 3, we can say that the majority of drugs are presented in the pharmacy by domestic manufacturers (54.53%), in second place are drugs produced in India third place was shared by the countries: Poland, Croatia, Belgium, Germany, the Czech Republic, the United States -4.55%.
Price analysis of medicines, as noted in the literature, is a very important aspect in the study of the range and availability of medicines [10] / Medicines intended for the treatment of skin diseases are presented in pharmacies in va price categories (Table 7).
Based on Table 7, we will analyze the price categories of medicines intended for the treatment of skin diseases ( Table 8).
The structure of the price categories of medicines intended for the treatment of skin diseases is shown in Fig. 4. 100,0

Structure of price categories of medicines intended for the treatment of skin diseases
The structure of the countries producing medicines intended for the treatment of skin say that the majority of drugs are presented in the pharmacy by domestic manufacturers (54.53%), in second place are drugs produced in India -18.17%; the third place was shared by the countries: Poland, Croatia, Belgium, Germany, the Czech Republic, Price analysis of medicines, as noted in the literature, is a very important aspect in the study of the range and availability of medicines [10] / Medicines intended for the treatment of skin diseases are presented in pharmacies in various Based on Table 7, we will analyze the price categories of medicines intended for the treatment of skin diseases ( Table 8).
The structure of the price categories of medicines intended for the treatment of skin The analysis of price categories of pharmaceuticals for the treatment of skin diseases revealed that in the price category from 100 to 200 RUB presents 22,73% of drugs; in the category from 200 to 300 rubles -300 to 400 rubles from 33.73%; from 400 to 700 rubles -on 4,55%.

CONCLUSION
During the analysis, the following data were obtained. The range under study is represented in the pharmacy by 22 items. The analysis of dosage forms of medicines intended for the treatment of skin diseases showed that liquid dosage forms accounted for 22.73%; solid dosage forms -4.55%; soft dosage forms 59.08%; gaseous dosage forms -13.64%. When analyzing the drugs, it was revealed that the largest number of synthetic drugs in the assortment is 68.18%; the share of herbal drugs was 31.82%. Analysis of the producing countries showed that most of the drugs presented to the pharmacy by domestic producers (54,53%), in the second place drugs manufactured in India 18,17%; third place was shared by countries:

Structure of price categories of medicines intended for the treatment of skin diseases
The analysis of price categories of pharmaceuticals for the treatment of skin diseases revealed that in the price category from 100 to 200 RUB presents 22,73% of drugs; in the -49,89%; from rubles from 33.73%; from 400 to 700 During the analysis, the following data were obtained. The range under study is represented in the pharmacy by 22 items. The analysis of dosage forms of medicines intended for the treatment of skin diseases showed that liquid dosage forms accounted for 22.73%; solid 4.55%; soft dosage forms-13.64%. When analyzing the drugs, it was revealed that the largest number of synthetic drugs in the assortment is 68.18%; the share of herbal drugs was 31.82%. Analysis of the producing countries showed that most of the drugs presented to the pharmacy by domestic producers (54,53%), in the second place drugs manufactured in Indiashared by countries: Poland, Croatia, Belgium, Germany, Czech Republic, USA -4,55%. The analysis of price categories of pharmaceuticals for the treatment of skin diseases revealed that in the price category from 100 to 200 RUB presents 22,73% of drugs; in the category from 200 to 300 rubles-49,89%; from 300 to 400 rubles from 33.73%; from 400 to 700 rubles -on 4,55%.

DISCLAIMER
The products used for this research are commonly and predominantly used products in our area of research and country. There is absolutely no conflict of interest between the authors and producers of the products because we do not intend to use these products as an avenue for any litigation, but for the advancement of knowledge. Also, the research was not funded by the producing company rather it was funded by personal efforts of the authors.

CONSENT
It's not applicable.

ETHICAL APPROVAL
It's not applicable.